PulmCCM

Share this post
Creepy ... MRSA's "MIC creep" to vancomycin portends worse outcomes
www.pulmccm.org

Creepy ... MRSA's "MIC creep" to vancomycin portends worse outcomes

Apr 17, 2011
Share this post
Creepy ... MRSA's "MIC creep" to vancomycin portends worse outcomes
www.pulmccm.org

Overt vancomycin resistance in MRSA is still unusual, but ID docs are worried about the bug's rising minimum inhibitory concentrations in some regions, with MICs > 1 mcg/mL associated with worse outcomes. Kullar et al retrospectively looked at Detroit's Henry Ford Hospital's 5-year micro data in 320 patients with MRSA bacteremia, reporting a 52% rate of vancomycin treatment failure. Vanco MIC > 1 had an odds ratio of 1.5 for treatment failure. They suggest targeting high troughs of 15-20 mg/mL and/or the more complex pharmacokinetic calculation, the 24-hour-area-under-the-curve-to-MIC (24-hr AUC/MIC) > 421. Clin Infect Dis 2011;52:975-981.

Share this post
Creepy ... MRSA's "MIC creep" to vancomycin portends worse outcomes
www.pulmccm.org
Comments
TopNew

No posts

Ready for more?

© 2023 PulmCCM
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great writing